Revelan un fármaco que frena el avance del cáncer de mama
Un ensayo clínico internacional realizado por el laboratorio Destiny Breast-03 reveló que el fármaco llamado “Trastuzumab Deruxtecan” actúa de manera efectiva y segura contra las
Un ensayo clínico internacional realizado por el laboratorio Destiny Breast-03 reveló que el fármaco llamado “Trastuzumab Deruxtecan” actúa de manera efectiva y segura contra las
Científicos del Instituto de Ciencias Biomédicas de la Universidad Estatal de Georgia, en Estados Unidos, determinaron que el medicamento antiviral, MK-4482/EIDD-2801 o molnupiravir, es capaz
Copyright © 2020 VPI TV – Developed by Rubik
Cookie | Duración | Descripción |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |